Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
M & A In Vitro Diagnostics Coronavirus COVID-19

Novo Holdings Acquires BBI Group In Deal Worth Over $400M

Executive Summary

To bolster its life sciences and diagnostics portfolios, Novo Holdings has made another major investment to acquire BBI Group.

You may also be interested in...



Venture Life Grabs BBI And Leading BV Brand Balance Activ

UK-based Venture Life has gained a foothold in the growing women's health category with the acquisition of BBI Healthcare and its leading OTC BV treatment Balance Activ.

More IVD Mergers: Agilent Buys Resolution, Hologic Acquires Diagenode

Hologic made its third big acquisition of 2021 and Agilent agreed to pay up to $695m for Resolution Bioscience to extend its precision oncology capabilities.

Boston Scientific Makes Half Billion Dollar GI Endosurgery Play

Boston Scientific is greatly increasing its GI endosurgery capabilities with the acquisition of Apollo Endosurgery, a manufacturer of various device for weight loss-related surgeries.

Table

View full table

Topics

Related Companies

Tags:
M & A In Vitro Diagnostics Coronavirus COVID-19
Latest News

FDA Warns Eye Care Company Conducting Unapproved Clinical Trial Of Drug-Device Product

European Regulatory Roundup, November 2022: EU MDR Situation Now Critical

Minute Insight: GE Healthcare Partners With MediView XR To Create AR Solution For Integrated MR Imaging

CMR Signs Deal With J&J To Bring Robots To Europe And South America

See All
UsernamePublicRestriction

Register

MT144070

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By